Floatz logo

Eslicarbazepine Acetate

Aging Disorder

Centre Hospitalier Saint Joseph Saint Luc de LyonSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Aging Disorder cohort.

Asset / SponsorPhaseRating
FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Washington University School of Medicine
Phase 2CCC
Dasatinib
Washington University School of Medicine
Phase 2CCC

Same molecule, other indications

Eslicarbazepine Acetate is also rated in:

focal epilepsyDormant
A
Indicative ·
82 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
74 / 100
View asset →
postherpetic neuralgiaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →